Cagrilintide (10mg)

Cagrilintide (10mg): Product Description

Cagrilintide is a synthetic, long-acting analog of the peptide hormone amylin. Its modified peptide structure was developed for controlled investigation of amylin-receptor signaling and extended molecular activity in laboratory systems. It is a comparatively large research peptide containing structural modifications that distinguish it from native human amylin.

Experimental studies involving Cagrilintide may focus on amylin-receptor activation, metabolic signaling, nutrient-response pathways, energy-balance mechanisms and cellular communication related to satiety-associated systems. These areas represent lines of scientific investigation and should not be presented as established therapeutic outcomes.

Researchers should account for the compound’s modified structure, molecular size, solubility, stability and assay-specific behavior when designing experiments. Analytical information may differ depending on how the molecular formula treats counterions, salts or other formulation components. The product-specific Certificate of Analysis should therefore be used as the final authority for identity, purity and measured molecular characteristics.

lists Cagrilintide 10 mg at a purity of at least 99% by HPLC and restricts it to in-vitro laboratory use.

Research Specifications

Molecular Formula: C194H312N54O59

Molecular Weight: Approximately 4,409 g/mol

Compound Type: Synthetic long-acting amylin analog

Presentation: 10 mg

Purity: ≥99% by HPLC

Research Focus: Amylin-receptor and metabolic-signaling models

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.